INDUS (INH) CMD Presentation summary
Event summary combining transcript, slides, and related documents.
CMD Presentation summary
6 Jun, 2025Key takeaways
Targeting EUR 3 billion in sales and over EUR 330 million adjusted EBITA by 2030, driven by internationalization, M&A, and technology focus.
Financial strength enables EUR 500 million investment in acquisitions by 2030.
Emphasis on innovation, operational excellence, and divestment of underperforming assets.
Technology-driven growth with focus on AI, digitization, and new technology fields.
Business and financial performance 2024
Revenue and EBIT met expectations, supported by improved H2 performance despite economic headwinds.
Four acquisitions contributed EUR 18.4 million in revenue; total acquisition spend EUR 29.4 million.
Free cash flow reached EUR 135.4 million, above target, supporting future growth.
Equity ratio increased to 38.7%, net debt/EBITDA at 2.4x, and attractive dividend of EUR 1.20 per share proposed.
EUR 44.7 million returned to shareholders via share buybacks.
Segment performance and outlook
Engineering: Stable sales (-0.5%), EBITA margin at 9.7%; muted order book but guidance for slight growth in 2025.
Infrastructure: Sales down 3.9%, but EBITA margin improved to 10.6%; order intake stable, growth expected in 2025.
Materials: Sales declined 8.9%, EBITA margin at 8.8%; order backlog shrank, slight sales increase expected in 2025.
Group 2025 guidance: Sales EUR 1.75–1.85 billion, adjusted EBITA EUR 150–175 million, margin 8.5–10%.
Latest events from INDUS
- Sales and EBIT fell, but EPS and free cash flow rose; guidance lowered amid economic headwinds.INH
Q2 20242 Mar 2026 - Sales stable, margins pressured by tariffs; guidance and strong H2 outlook confirmed.INH
Q2 20252 Mar 2026 - Record Q3 revenue and 10% EBITA growth, with guidance reaffirmed amid economic headwinds.INH
Q3 202512 Nov 2025 - Targeting EUR 3 billion sales by 2030, INDUS drives growth via acquisitions and resilient cash flow.INH
16th IIF - International Investment Forum8 Oct 2025 - Sales and EBIT fell year-over-year, but Q3 margins and cash flow improved.INH
Q3 202413 Jun 2025 - Sales and earnings fell, but order intake and equity ratio improved in Q1 2025.INH
Q1 20255 Jun 2025 - 2024 results met guidance, with resilient EBIT, improved equity ratio, and strategic acquisitions.INH
Q4 20245 Jun 2025